Seeking Alpha

YM BioSciences (YMI) says its buyout by a wholly owned subsidiary of Gilead Sciences (GILD...

YM BioSciences (YMI) says its buyout by a wholly owned subsidiary of Gilead Sciences (GILD +0.8%) has been endorsed by proxy advisory firms Institutional Investor Services and Glass, Lewis & Co. ISI says the all-cash deal offers a satisfactory premium, while Glass Lewis also notes that the YMI board of directors conducted a reasonable review of strategic alternatives available to the company prior to entering into the proposed agreement.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs